The Cameron Institute – a Canadian not-for-profit public policy think-tank – released a report highlighting the importance of public-private partnerships and of intellectual property protections to improving global health. The evidence in this report (Pharmaceutical Access in Least Developed Countries: on-the-ground barriers and industry successes) strongly supports North-South, public-private partnerships as the preferred means by which to improve access to care and public health outcomes in least-developed countries.
Sustainable development is the way of the future for both North and South. In order for there to be sustainable healthcare enterprise and optimal health outcomes in the least-developed countries, there must also be the necessary infrastructure, health human resources, political stability, and professional administrative legal structures.
– Dr. D. Wayne Taylor Ph.D., F.CIM, Executive Director of The Cameron Institute
The 200-page report shows that the research-based pharmaceutical industry has sponsored or participated in over 150 public-private partnerships that have successfully improved access to drugs – as well as health outcomes – for the 50 least developed countries.
Filed under: Africa, Commentary on news & events, Public health | Tagged: access to medicines, Africa, Canada, global health, intellectual property, Public health, public-private partnerships, research-based pharmaceutical industry | Leave a Comment »